iA Global Asset Management’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.6M Sell
41,775
-903
-2% -$395K 0.2% 102
2026
Q1
$19.7M Sell
42,678
-1,447
-3% -$732K 0.28% 78
2025
Q4
$25M Buy
44,125
+2,564
+6% +$1.37M 0.32% 70
2025
Q3
$18.6M Sell
41,561
-7,045
-14% -$3.38M 0.25% 83
2025
Q2
$26.4M Sell
48,606
-2,310
-5% -$1.21M 0.4% 58
2025
Q1
$25.2M Buy
50,916
+1,121
+2% +$620K 0.43% 48
2024
Q4
$26M Buy
49,795
+2,506
+5% +$1.31M 0.46% 43
2024
Q3
$23.2M Buy
47,289
+1,279
+3% +$595K 0.41% 52
2024
Q2
$20.5M Buy
46,010
+1,580
+4% +$629K 0.39% 53
2024
Q1
$17.7M Buy
44,430
+1,471
+3% +$556K 0.36% 58
2023
Q4
$14.5M Buy
42,959
+1,940
+5% +$578K 0.33% 61
2023
Q3
$12M Buy
41,019
+15,077
+58% +$4.71M 0.32% 76
2023
Q2
$8.87M Buy
+25,942
New +$7.85M 0.24% 82

Other funds holding ISRG

iA Global Asset Management's ISRG Position: Q2 2026 in Review

iA Global Asset Management reduced its Intuitive Surgical (ISRG) stake by 2.1% in Q2 2026, selling an estimated $395K and leaving 41,775 shares worth $16.6M. The position accounts for 0.2% of the portfolio, ranked #102.

iA Global Asset Management first reported a position in ISRG in Q2 2023 and has held it in 13 quarters since. The position peaked at $26.4M in Q2 2025. 2,232 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.

  • iA Global Asset Management held 41,775 shares of Intuitive Surgical worth $16.6M as of Q2 2026.
  • iA Global Asset Management sold 903 Intuitive Surgical shares in Q2 2026, an estimated $395K.
  • Intuitive Surgical made up 0.2% of iA Global Asset Management's portfolio in Q2 2026, its #102 holding.
  • iA Global Asset Management first reported a position in Intuitive Surgical in Q2 2023 and has held it in 13 quarters since.
  • iA Global Asset Management's Intuitive Surgical position peaked at $26.4M in Q2 2025.
  • 2,232 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.

Based on iA Global Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.